A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor. [electronic resource]
Producer: 20070206Description: 6737-47 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Antinuclear -- blood
- Biopsy
- Breast Neoplasms -- pathology
- Carcinoma -- pathology
- Colorectal Neoplasms -- pathology
- Cytokines -- blood
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Head and Neck Neoplasms -- pathology
- Humans
- Male
- Melanoma -- pathology
- Middle Aged
- Neoplasms -- therapy
- Oncolytic Virotherapy -- adverse effects
- Oncolytic Viruses
- Recombinant Proteins
- Simplexvirus -- immunology
- Skin Neoplasms -- pathology
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.